Anneke C Blackburn 30th Lorne Cancer Conference 2018

Abstracts this author is presenting:

• DiCAM (DiChloroAcetate in Myeloma): a trial of the glycolytic phenotype inhibitor dichloroacetate for the treatment of multiple myeloma patients in partial remission — Poster Session 1